Aelis Farma SA (AELIS) Stock Statistics & Valuation Metrics

Aelis Farma SA has a market cap or net worth of €15.27M. The enterprise value is €15.57M.

Aelis Farma SA has 13,706,586 shares outstanding. The number of shares has decreased by -2.65% in one year.

Aelis Farma SA’s return on equity (ROE) is -1.45 and return on invested capital (ROIC) is -67.01%.

The current PE Ratio of Aelis Farma SA is ―. Aelis Farma SA’s PEG ratio is 0.19.

In the last 12 months, Aelis Farma SA had revenue of 2.08M and earned -6.43M in profits. Earnings per share was -0.47.

In the last 12 months, operating cash flow was -5.37M and capital expenditures -4.00K, giving a free cash flow of -5.37M billion.

Aelis Farma SA pays an annual dividend of ―, resulting in a dividend yield of ―

Aelis Farma SA upcoming earnings date is Sep 15, 2026, Before Open (Not Confirmed).

Aelis Farma SA as a current ratio of 4.40, with Debt / Equity ratio of 148.64%

In the past 12 months, Aelis Farma SA has paid -706.00K in taxes.

Aelis Farma SA EV to EBITDA ratio is -1.73, with an EV/FCF ratio of -2.58.

Aelis Farma SA has €8.21M in cash and marketable securities with €6.60M in debt, giving a net cash position of €1.61M billion.

Gross margin is 35.80%, with operating margin of -397.36%, and net profit margin of -308.73%.

The average price target for Aelis Farma SA is ―, which is 11.43% higher than the current price. The consensus rating is ―